U-Neuron Biomedical

U-Neuron Biomedical EBIT per Share

The EBIT per Share of U-Neuron Biomedical (6973.TWO) as of Oct 11, 2026 is -2.03 TWD. In the previous year, EBIT per Share was -3.38 TWD — a change of -40.06% (higher).

EBIT per Share

-2.03TWD

YoY

-40.06%

Last updated:

EBIT per Share of U-Neuron Biomedical is 2024 -2.03 TWD. EBIT per Share of U-Neuron Biomedical was 2023 -3.38 TWD. It decreases by -40.06% higher compared to the previous year.

The U-Neuron Biomedical EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2021
-0.51 TWD
Jan 1, 2022
-1.48 TWD
Jan 1, 2023
-3.38 TWD
Jan 1, 2024
-2.03 TWD
The U-Neuron Biomedical EBIT per Share history
YEAREBIT per ShareYoY
-2.03TWD-40.06%
-3.38TWD+128.92%
-1.48TWD+189.90%
-0.51TWD—
Access this data via the Eulerpool API
Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

EBIT per Share of U-Neuron Biomedical is -2.03 TWD in 2024.

EBIT per Share of U-Neuron Biomedical changed from -3.38 TWD to -2.03 TWD, representing a -40.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — U-Neuron Biomedical

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — U-Neuron Biomedical